ASLAN Pharmaceuticals Ltd has a consensus price target of $10.5 based on the ratings of 23 analysis. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on May 3, 2024, April 23, 2024, and April 15, 2024, respectively. With an average price target of $9 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 350.00% upside for ASLAN Pharmaceuticals Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/03/2024 | Buy Now | 350% | HC Wainwright & Co. | Yi Chen | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
04/23/2024 | Buy Now | 350% | HC Wainwright & Co. | Yi Chen | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
04/15/2024 | Buy Now | 350% | HC Wainwright & Co. | Yi Chen | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
03/18/2024 | Buy Now | 350% | HC Wainwright & Co. | Yi Chen | $136 → $72 | Maintains | Buy | Get Alert |
03/13/2024 | Buy Now | 400% | Piper Sandler | Edward Tenthoff | $120 → $80 | Reiterates | Overweight → Overweight | Get Alert |
03/11/2024 | Buy Now | 650% | Piper Sandler | Edward Tenthoff | $120 → $120 | Maintains | Overweight | Get Alert |
11/06/2023 | Buy Now | 750% | HC Wainwright & Co. | Yi Chen | → $136 | Reiterates | Buy → Buy | Get Alert |
08/14/2023 | Buy Now | 650% | Roth MKM | Dylan Dupuis | → $120 | Reiterates | Buy → Buy | Get Alert |
08/14/2023 | Buy Now | 750% | HC Wainwright & Co. | Yi Chen | → $136 | Reiterates | Buy → Buy | Get Alert |
07/07/2023 | Buy Now | 750% | HC Wainwright & Co. | Yi Chen | → $136 | Reiterates | Buy → Buy | Get Alert |
06/26/2023 | Buy Now | 750% | HC Wainwright & Co. | Yi Chen | → $136 | Reiterates | Buy → Buy | Get Alert |
06/23/2023 | Buy Now | 750% | HC Wainwright & Co. | Yi Chen | → $136 | Reiterates | Buy → Buy | Get Alert |
05/31/2023 | Buy Now | 650% | Roth MKM | Dylan Dupuis | → $120 | Initiates | → Buy | Get Alert |
04/28/2023 | Buy Now | 750% | HC Wainwright & Co. | Yi Chen | $160 → $136 | Maintains | Buy | Get Alert |
03/27/2023 | Buy Now | 900% | HC Wainwright & Co. | Yi Chen | → $160 | Reiterates | → Buy | Get Alert |
03/20/2023 | Buy Now | 900% | HC Wainwright & Co. | Yi Chen | → $160 | Reiterates | → Buy | Get Alert |
03/01/2023 | Buy Now | 125% | HC Wainwright & Co. | Yi Chen | → $180 | Reiterates | → Buy | Get Alert |
02/27/2023 | Buy Now | 50% | Piper Sandler | Edward Tenthoff | $160 → $120 | Maintains | Overweight | Get Alert |
02/27/2023 | Buy Now | 125% | HC Wainwright & Co. | Yi Chen | $280 → $180 | Maintains | Buy | Get Alert |
09/16/2022 | Buy Now | 100% | Piper Sandler | Edward Tenthoff | $120 → $160 | Maintains | Overweight | Get Alert |
08/15/2022 | Buy Now | 250% | HC Wainwright & Co. | Yi Chen | $320 → $280 | Maintains | Buy | Get Alert |
05/23/2022 | Buy Now | 50% | Piper Sandler | Edward Tenthoff | $320 → $120 | Maintains | Overweight | Get Alert |
07/09/2021 | Buy Now | 300% | Jefferies | Maury Raycroft | → $320 | Initiates | → Buy | Get Alert |
The latest price target for ASLAN Pharma (NASDAQ:ASLN) was reported by HC Wainwright & Co. on May 3, 2024. The analyst firm set a price target for $9.00 expecting ASLN to rise to within 12 months (a possible 350.00% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for ASLAN Pharma (NASDAQ:ASLN) was provided by HC Wainwright & Co., and ASLAN Pharma reiterated their buy rating.
There is no last upgrade for ASLAN Pharma
There is no last downgrade for ASLAN Pharma.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ASLAN Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ASLAN Pharma was filed on May 3, 2024 so you should expect the next rating to be made available sometime around May 3, 2025.
While ratings are subjective and will change, the latest ASLAN Pharma (ASLN) rating was a reiterated with a price target of $9.00 to $9.00. The current price ASLAN Pharma (ASLN) is trading at is $2.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.